Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 5 May 2022
Accepted: 9 March 2023
First Online: 8 July 2023
Declarations
:
: The study was conducted in compliance with the study protocol and the Declaration of Helsinki and received approval from the AMREF Ethical and Scientific Review Committee (approval number P618/2019). Signed informed consent was collected from patients or their legal guardians.
: Not applicable.
: JC declares no conflict of interest. JM received direct payments from AstraZeneca. MB was an employee of AstraZeneca at the time of the conduct and analysis of the study.
